Diffuse Midline Glioma, H3 K27M-Mutant — Trials

Diffuse Midline Glioma, H3 K27M-Mutant — Trials · CancerIndex

Clinical trials

Registered studies

28 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 17
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 29%
Top sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05835687	Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors	active not recruiting	Phase 1	29	St. Jude Children's Research HospitalOTHER	1	Jul 6, 2026	clinicaltrials

Data updated 22 days agoSource updated Jul 6, 2026source: clinicaltrials